Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical Cancer

SIMPLE SUMMARY: Mitotane is the only drug approved for treatment of adrenocortical cancer. Although mitotane is a derivative of the pesticide dichlorodiphenyltrichloroethane (DDT), limited data are available on its toxicity. Herein, we reported on the type and frequency of mitotane adverse events an...

Descripción completa

Detalles Bibliográficos
Autores principales: Basile, Vittoria, Puglisi, Soraya, Calabrese, Anna, Pia, Anna, Perotti, Paola, Berruti, Alfredo, Reimondo, Giuseppe, Terzolo, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565701/
https://www.ncbi.nlm.nih.gov/pubmed/32937772
http://dx.doi.org/10.3390/cancers12092615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565701/
https://www.ncbi.nlm.nih.gov/pubmed/32937772
http://dx.doi.org/10.3390/cancers12092615

Ejemplares similares